Clinical Trial Update: Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) [Phase 3]

View source ↗

Summary

This document describes a Phase 3 clinical trial comparing selective internal radiation therapy (SIRT) with Sorafenib in locally advanced hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Selective Internal Radiation Therapy (SIRT) (selective internal radiation therapy)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Singapore General Hospital | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN